Latest News

Click here to read the full letter.

ResearchersAgainstAlzheimer’s agrees with the importance of diagnosis and treatments at much earlier stages of Alzheimer’s disease. This draft guidance is based on the emerging understanding of Alzheimer’s research that treatments aimed at people showing overt functional impairments due to dementia won’t work because the damage to the brain may be too extensive at that point in the progression of the disease. Therefore, the appropriate response to this recently-­developed understanding is, as noted in the well-­considered draft guidance document of the FDA, to rely on a demonstration of a positive impact...

Pressure is mounting for Washington to find a way to avoid the automatic spending reductions set to begin March 1, with President Barack Obama Tuesday urging Congress to stop the "meat-cleaver approach" that he says will undermine U.S. military strength and "eviscerate job creating investments in education and energy and medical research."

Click Here to Learn More

Ara Khachaturian, PhD, from Prevent Alzheimer's Disease 2020 discussed the development process for a National Institutional Review Board, challenges ahead, and how a well-designed, highly-qualified, and responsive National Institutional Review Board promises to provide better safeguards for clinical trial participants while more efficiently accelerating the scientific enterprise to bend the curve of Alzheimer's disease.

This call was presented by the LEAD Coalition and ResearchersAgainstAlzheimer's.

Dr. Frank LaFerla is Director of the Institute for Memory Impairments and Neurological Disorders, University of California, Irvine. He was the first to use stem cell technology for use in mice engineered for both the plaques and tangles that are characteristic of human Alzheimer’s disease. Recently, his group reported data that shows that neural stem cells can rescue – and actually restore – memory and function in mice, which have Alzheimer’s-like cognitive deficits. During this call he discusses his research and answers questions. Click here for a recording and transcript....

For the first time ever, the US government has adopted a national strategic plan to prevent and effectively treat Alzheimer’s disease by 2025. Dr. Ron Petersen, Chairman of the National Alzheimer’s Advisory Council on Research, Care and Services and Director of the Mayo Clinic’s Alzheimer’s Disease Research Center summarized what is in the National Plan and the first steps in its implementation. Click here for a recording and transcript.

The full text of the letter is available here (PDF).

The full text of the letter is available here (PDF).

Pages